Skip to main content
. 2021 Jun 30;13(7):994. doi: 10.3390/pharmaceutics13070994

Figure 5.

Figure 5

FTIR spectra of following: (a) sulfonatocalix[4]naphthalene (C), (b) meloxicam (ME), (c) physical mixture (PM), (d) kneaded (KN), and (e) coevaporate (CO) powders.